William Blair & Company
NYMX

William Blair & Company’s Nymox Pharmaceutical Corp NYMX Stock Holding History

William Blair & Company’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-13,000
Closed -$56K – 2160
2014
Q3 		$56K Hold
13,000
– – ﹤0.01% 2045
2014
Q2 		$64K Hold
13,000
– – ﹤0.01% 2016
2014
Q1 		$70K Buy
+13,000
New +$75.4K ﹤0.01% 1965

Other funds holding NYMX

AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
WP
WMS Partners Towson, Maryland $1.78B AUM 11.82% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
MCM
Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BAS
Brown Advisory Securities Baltimore, Maryland $27.3M AUM 10.67% 1-Year Est. Return
GG
Gofen & Glossberg Chicago, Illinois $3.89B AUM 11.97% 1-Year Est. Return

William Blair & Company's NYMX Position: Q4 2014 in Review

William Blair & Company sold out of Nymox Pharmaceutical Corp (NYMX) in Q4 2014, closing a stake of 13,000 shares — an estimated $56K sold.

William Blair & Company first reported a position in NYMX in Q1 2014 and held it in 3 quarters. The position peaked at $70K in Q1 2014. 25 funds tracked by Wall St. Rank hold NYMX as of Q4 2014.

  • William Blair & Company reported no remaining Nymox Pharmaceutical Corp position as of Q4 2014 after selling out during the quarter.
  • William Blair & Company sold 13,000 Nymox Pharmaceutical Corp shares in Q4 2014, an estimated $56K.
  • William Blair & Company first reported a position in Nymox Pharmaceutical Corp in Q1 2014 and held it in 3 quarters.
  • William Blair & Company's Nymox Pharmaceutical Corp position peaked at $70K in Q1 2014.
  • 25 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q4 2014.

Based on William Blair & Company's 13F filing for Q4 2014, filed 5 Feb 2015.